Genomic Predictors of Papillary Microcarcinoma Disease Progression — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Genomic Predictors of Papillary Microcarcinoma Disease Progression — Stella

Recruiting

Back to Papillary Microcarcinoma trials

Trial locations(1 site)

United States

Memorial Sloan Kettering Cancer Center, New York, New York

Key details

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

Ohio State University, University of Pittsburgh

Enrollment target

~750 participants

Started

December 2014

Primary completion

December 2027

Age range

18 Years and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov